We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cancer Diagnosis by Mass Spectroscopy

By Biotechdaily staff writers
Posted on 23 Nov 2005
Researchers have converted a mass spectrometer, a common instrument in analytic chemistry laboratories, for use in diagnosing cancer and monitoring tumor growth.

Investigators at Purdue University (West Lafayette, IN, USA) and Vanderbilt University (Nashville, TN, USA) developed an advanced sampling mechanism that enhanced a mass spectrometer used for electrospray ionization spectroscopy and turned it into a medical diagnostic tool.

In electrospray ionization, a liquid is pushed through a very small charged metal capillary by a carrier gas. More...
The liquid contains the substance that is to be studied, the analyte, as well as a large amount of solvent, which is usually much more volatile than the analyte. The charge contained in the capillary transfers to the liquid, which charges the analyte molecule. As like charges repel, the liquid pushes itself out of the capillary and forms an aerosol of small droplets about 10 µm across. A neutral carrier gas is sometimes used to evaporate the neutral solvent in the small droplets, which brings the charged analyte molecules closer together. The proximity of the molecules becomes unstable, however, and as the similarly charged molecules come closer together, the droplets explode. This process repeats itself until the analyte is free of solvent and is a lone ion. The lone ion then continues along to a mass analyzer.

The improved detector described in this study is a handheld wand that directs a fine water mist at a surface and then absorbs the fluid after the droplets have mixed with the material in the sample. Details were published in the November 4, 2005, issue of Angewandte Chemie.

With this method--nicknamed DESI (desorption electrospray ionization)--investigators were able to resolve chemical differences between sample areas as small as a half-millimeter. This level of resolution was sufficient to allow detection of very small tumors in a tissue sample. The technique could differentiate between diseased and non-diseased regions of tissue samples within a few seconds.

Senior author Dr. R. Graham Cooks, professor of analytic chemistry at Purdue University, said, "For now, we have shown that DESI can quickly provide medically relevant information to physicians, including the location of the boundary between cancerous and healthy tissue, accurate to within the diameter of just a few cells. That gives us cause for optimism.”




Related Links:
Purdue University
Vanderbilt University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Chromogenic Culture System
InTray™ COLOREX™ ECC
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.